NFE2L2 and cancer: Moreover, activated transcription factors such as nuclear factor erythroid 2-related factor 2 (NRF2) and hypoxia inducible factor-1α (HIF-1α) promote cancer cells to adapt to drug-mediated oxidative stress (chemoresistance) [40,41].